GLOBAL VASOMOTOR SYMPTOMS OF MENOPAUSE TREATMENT MARKET 2022 BY COMPANY, REGIONS, TYPE AND APPLICATION, FORECAST TO 2028

Jul 2022 85
Table of Contents

1 Market Overview
1.1 Product Overview and Scope of Vasomotor Symptoms of Menopause Treatment
1.2 Classification of Vasomotor Symptoms of Menopause Treatment by Type
1.2.1 Overview: Global Vasomotor Symptoms of Menopause Treatment Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Vasomotor Symptoms of Menopause Treatment Revenue Market Share by Type in 2021
1.2.3 Estetrol
1.2.4 Fezolinetant
1.2.5 FP-101
1.2.6 HBN-2
1.2.7 Others
1.3 Global Vasomotor Symptoms of Menopause Treatment Market by Application
1.3.1 Overview: Global Vasomotor Symptoms of Menopause Treatment Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Homecare
1.3.4 Clinic
1.4 Global Vasomotor Symptoms of Menopause Treatment Market Size & Forecast
1.5 Global Vasomotor Symptoms of Menopause Treatment Market Size and Forecast by Region
1.5.1 Global Vasomotor Symptoms of Menopause Treatment Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Vasomotor Symptoms of Menopause Treatment Market Size by Region, (2017-2022)
1.5.3 North America Vasomotor Symptoms of Menopause Treatment Market Size and Prospect (2017-2028)
1.5.4 Europe Vasomotor Symptoms of Menopause Treatment Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Vasomotor Symptoms of Menopause Treatment Market Size and Prospect (2017-2028)
1.5.6 South America Vasomotor Symptoms of Menopause Treatment Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Vasomotor Symptoms of Menopause Treatment Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Vasomotor Symptoms of Menopause Treatment Market Drivers
1.6.2 Vasomotor Symptoms of Menopause Treatment Market Restraints
1.6.3 Vasomotor Symptoms of Menopause Treatment Trends Analysis
2 Company Profiles
2.1 Amgen Inc.
2.1.1 Amgen Inc. Details
2.1.2 Amgen Inc. Major Business
2.1.3 Amgen Inc. Vasomotor Symptoms of Menopause Treatment Product and Solutions
2.1.4 Amgen Inc. Vasomotor Symptoms of Menopause Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Amgen Inc. Recent Developments and Future Plans
2.2 EndoCeutics, Inc.
2.2.1 EndoCeutics, Inc. Details
2.2.2 EndoCeutics, Inc. Major Business
2.2.3 EndoCeutics, Inc. Vasomotor Symptoms of Menopause Treatment Product and Solutions
2.2.4 EndoCeutics, Inc. Vasomotor Symptoms of Menopause Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 EndoCeutics, Inc. Recent Developments and Future Plans
2.3 Euroscreen S.A.
2.3.1 Euroscreen S.A. Details
2.3.2 Euroscreen S.A. Major Business
2.3.3 Euroscreen S.A. Vasomotor Symptoms of Menopause Treatment Product and Solutions
2.3.4 Euroscreen S.A. Vasomotor Symptoms of Menopause Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Euroscreen S.A. Recent Developments and Future Plans
2.4 MenoGeniX, Inc.
2.4.1 MenoGeniX, Inc. Details
2.4.2 MenoGeniX, Inc. Major Business
2.4.3 MenoGeniX, Inc. Vasomotor Symptoms of Menopause Treatment Product and Solutions
2.4.4 MenoGeniX, Inc. Vasomotor Symptoms of Menopause Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 MenoGeniX, Inc. Recent Developments and Future Plans
2.5 Mithra Pharmaceuticals S.A.
2.5.1 Mithra Pharmaceuticals S.A. Details
2.5.2 Mithra Pharmaceuticals S.A. Major Business
2.5.3 Mithra Pharmaceuticals S.A. Vasomotor Symptoms of Menopause Treatment Product and Solutions
2.5.4 Mithra Pharmaceuticals S.A. Vasomotor Symptoms of Menopause Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Mithra Pharmaceuticals S.A. Recent Developments and Future Plans
2.6 Pherin Pharmaceuticals, Inc.
2.6.1 Pherin Pharmaceuticals, Inc. Details
2.6.2 Pherin Pharmaceuticals, Inc. Major Business
2.6.3 Pherin Pharmaceuticals, Inc. Vasomotor Symptoms of Menopause Treatment Product and Solutions
2.6.4 Pherin Pharmaceuticals, Inc. Vasomotor Symptoms of Menopause Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Pherin Pharmaceuticals, Inc. Recent Developments and Future Plans
2.7 Pivot Pharmaceuticals Inc
2.7.1 Pivot Pharmaceuticals Inc Details
2.7.2 Pivot Pharmaceuticals Inc Major Business
2.7.3 Pivot Pharmaceuticals Inc Vasomotor Symptoms of Menopause Treatment Product and Solutions
2.7.4 Pivot Pharmaceuticals Inc Vasomotor Symptoms of Menopause Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Pivot Pharmaceuticals Inc Recent Developments and Future Plans
2.8 Radius Health, Inc.
2.8.1 Radius Health, Inc. Details
2.8.2 Radius Health, Inc. Major Business
2.8.3 Radius Health, Inc. Vasomotor Symptoms of Menopause Treatment Product and Solutions
2.8.4 Radius Health, Inc. Vasomotor Symptoms of Menopause Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Radius Health, Inc. Recent Developments and Future Plans
2.9 TherapeuticsMD, Inc.
2.9.1 TherapeuticsMD, Inc. Details
2.9.2 TherapeuticsMD, Inc. Major Business
2.9.3 TherapeuticsMD, Inc. Vasomotor Symptoms of Menopause Treatment Product and Solutions
2.9.4 TherapeuticsMD, Inc. Vasomotor Symptoms of Menopause Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 TherapeuticsMD, Inc. Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Vasomotor Symptoms of Menopause Treatment Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Vasomotor Symptoms of Menopause Treatment Players Market Share in 2021
3.2.2 Top 10 Vasomotor Symptoms of Menopause Treatment Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Vasomotor Symptoms of Menopause Treatment Players Head Office, Products and Services Provided
3.4 Vasomotor Symptoms of Menopause Treatment Mergers & Acquisitions
3.5 Vasomotor Symptoms of Menopause Treatment New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Vasomotor Symptoms of Menopause Treatment Revenue and Market Share by Type (2017-2022)
4.2 Global Vasomotor Symptoms of Menopause Treatment Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5.1 Global Vasomotor Symptoms of Menopause Treatment Revenue Market Share by Application (2017-2022)
5.2 Global Vasomotor Symptoms of Menopause Treatment Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6.1 North America Vasomotor Symptoms of Menopause Treatment Revenue by Type (2017-2028)
6.2 North America Vasomotor Symptoms of Menopause Treatment Revenue by Application (2017-2028)
6.3 North America Vasomotor Symptoms of Menopause Treatment Market Size by Country
6.3.1 North America Vasomotor Symptoms of Menopause Treatment Revenue by Country (2017-2028)
6.3.2 United States Vasomotor Symptoms of Menopause Treatment Market Size and Forecast (2017-2028)
6.3.3 Canada Vasomotor Symptoms of Menopause Treatment Market Size and Forecast (2017-2028)
6.3.4 Mexico Vasomotor Symptoms of Menopause Treatment Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7.1 Europe Vasomotor Symptoms of Menopause Treatment Revenue by Type (2017-2028)
7.2 Europe Vasomotor Symptoms of Menopause Treatment Revenue by Application (2017-2028)
7.3 Europe Vasomotor Symptoms of Menopause Treatment Market Size by Country
7.3.1 Europe Vasomotor Symptoms of Menopause Treatment Revenue by Country (2017-2028)
7.3.2 Germany Vasomotor Symptoms of Menopause Treatment Market Size and Forecast (2017-2028)
7.3.3 France Vasomotor Symptoms of Menopause Treatment Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Vasomotor Symptoms of Menopause Treatment Market Size and Forecast (2017-2028)
7.3.5 Russia Vasomotor Symptoms of Menopause Treatment Market Size and Forecast (2017-2028)
7.3.6 Italy Vasomotor Symptoms of Menopause Treatment Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Vasomotor Symptoms of Menopause Treatment Revenue by Type (2017-2028)
8.2 Asia-Pacific Vasomotor Symptoms of Menopause Treatment Revenue by Application (2017-2028)
8.3 Asia-Pacific Vasomotor Symptoms of Menopause Treatment Market Size by Region
8.3.1 Asia-Pacific Vasomotor Symptoms of Menopause Treatment Revenue by Region (2017-2028)
8.3.2 China Vasomotor Symptoms of Menopause Treatment Market Size and Forecast (2017-2028)
8.3.3 Japan Vasomotor Symptoms of Menopause Treatment Market Size and Forecast (2017-2028)
8.3.4 South Korea Vasomotor Symptoms of Menopause Treatment Market Size and Forecast (2017-2028)
8.3.5 India Vasomotor Symptoms of Menopause Treatment Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Vasomotor Symptoms of Menopause Treatment Market Size and Forecast (2017-2028)
8.3.7 Australia Vasomotor Symptoms of Menopause Treatment Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9.1 South America Vasomotor Symptoms of Menopause Treatment Revenue by Type (2017-2028)
9.2 South America Vasomotor Symptoms of Menopause Treatment Revenue by Application (2017-2028)
9.3 South America Vasomotor Symptoms of Menopause Treatment Market Size by Country
9.3.1 South America Vasomotor Symptoms of Menopause Treatment Revenue by Country (2017-2028)
9.3.2 Brazil Vasomotor Symptoms of Menopause Treatment Market Size and Forecast (2017-2028)
9.3.3 Argentina Vasomotor Symptoms of Menopause Treatment Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Vasomotor Symptoms of Menopause Treatment Revenue by Type (2017-2028)
10.2 Middle East & Africa Vasomotor Symptoms of Menopause Treatment Revenue by Application (2017-2028)
10.3 Middle East & Africa Vasomotor Symptoms of Menopause Treatment Market Size by Country
10.3.1 Middle East & Africa Vasomotor Symptoms of Menopause Treatment Revenue by Country (2017-2028)
10.3.2 Turkey Vasomotor Symptoms of Menopause Treatment Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Vasomotor Symptoms of Menopause Treatment Market Size and Forecast (2017-2028)
10.3.4 UAE Vasomotor Symptoms of Menopause Treatment Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

List of Tables
Table 1. Global Vasomotor Symptoms of Menopause Treatment Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Vasomotor Symptoms of Menopause Treatment Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Vasomotor Symptoms of Menopause Treatment Revenue (USD Million) by Region (2017-2022)
Table 5. Global Vasomotor Symptoms of Menopause Treatment Revenue Market Share by Region (2023-2028)
Table 6. Amgen Inc. Corporate Information, Head Office, and Major Competitors
Table 7. Amgen Inc. Major Business
Table 8. Amgen Inc. Vasomotor Symptoms of Menopause Treatment Product and Solutions
Table 9. Amgen Inc. Vasomotor Symptoms of Menopause Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. EndoCeutics, Inc. Corporate Information, Head Office, and Major Competitors
Table 11. EndoCeutics, Inc. Major Business
Table 12. EndoCeutics, Inc. Vasomotor Symptoms of Menopause Treatment Product and Solutions
Table 13. EndoCeutics, Inc. Vasomotor Symptoms of Menopause Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Euroscreen S.A. Corporate Information, Head Office, and Major Competitors
Table 15. Euroscreen S.A. Major Business
Table 16. Euroscreen S.A. Vasomotor Symptoms of Menopause Treatment Product and Solutions
Table 17. Euroscreen S.A. Vasomotor Symptoms of Menopause Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. MenoGeniX, Inc. Corporate Information, Head Office, and Major Competitors
Table 19. MenoGeniX, Inc. Major Business
Table 20. MenoGeniX, Inc. Vasomotor Symptoms of Menopause Treatment Product and Solutions
Table 21. MenoGeniX, Inc. Vasomotor Symptoms of Menopause Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Mithra Pharmaceuticals S.A. Corporate Information, Head Office, and Major Competitors
Table 23. Mithra Pharmaceuticals S.A. Major Business
Table 24. Mithra Pharmaceuticals S.A. Vasomotor Symptoms of Menopause Treatment Product and Solutions
Table 25. Mithra Pharmaceuticals S.A. Vasomotor Symptoms of Menopause Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Pherin Pharmaceuticals, Inc. Corporate Information, Head Office, and Major Competitors
Table 27. Pherin Pharmaceuticals, Inc. Major Business
Table 28. Pherin Pharmaceuticals, Inc. Vasomotor Symptoms of Menopause Treatment Product and Solutions
Table 29. Pherin Pharmaceuticals, Inc. Vasomotor Symptoms of Menopause Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Pivot Pharmaceuticals Inc Corporate Information, Head Office, and Major Competitors
Table 31. Pivot Pharmaceuticals Inc Major Business
Table 32. Pivot Pharmaceuticals Inc Vasomotor Symptoms of Menopause Treatment Product and Solutions
Table 33. Pivot Pharmaceuticals Inc Vasomotor Symptoms of Menopause Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Radius Health, Inc. Corporate Information, Head Office, and Major Competitors
Table 35. Radius Health, Inc. Major Business
Table 36. Radius Health, Inc. Vasomotor Symptoms of Menopause Treatment Product and Solutions
Table 37. Radius Health, Inc. Vasomotor Symptoms of Menopause Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. TherapeuticsMD, Inc. Corporate Information, Head Office, and Major Competitors
Table 39. TherapeuticsMD, Inc. Major Business
Table 40. TherapeuticsMD, Inc. Vasomotor Symptoms of Menopause Treatment Product and Solutions
Table 41. TherapeuticsMD, Inc. Vasomotor Symptoms of Menopause Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Global Vasomotor Symptoms of Menopause Treatment Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 43. Global Vasomotor Symptoms of Menopause Treatment Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 44. Breakdown of Vasomotor Symptoms of Menopause Treatment by Company Type (Tier 1, Tier 2 and Tier 3)
Table 45. Vasomotor Symptoms of Menopause Treatment Players Head Office, Products and Services Provided
Table 46. Vasomotor Symptoms of Menopause Treatment Mergers & Acquisitions in the Past Five Years
Table 47. Vasomotor Symptoms of Menopause Treatment New Entrants and Expansion Plans
Table 48. Global Vasomotor Symptoms of Menopause Treatment Revenue (USD Million) by Type (2017-2022)
Table 49. Global Vasomotor Symptoms of Menopause Treatment Revenue Share by Type (2017-2022)
Table 50. Global Vasomotor Symptoms of Menopause Treatment Revenue Forecast by Type (2023-2028)
Table 51. Global Vasomotor Symptoms of Menopause Treatment Revenue by Application (2017-2022)
Table 52. Global Vasomotor Symptoms of Menopause Treatment Revenue Forecast by Application (2023-2028)
Table 53. North America Vasomotor Symptoms of Menopause Treatment Revenue by Type (2017-2022) & (USD Million)
Table 54. North America Vasomotor Symptoms of Menopause Treatment Revenue by Type (2023-2028) & (USD Million)
Table 55. North America Vasomotor Symptoms of Menopause Treatment Revenue by Application (2017-2022) & (USD Million)
Table 56. North America Vasomotor Symptoms of Menopause Treatment Revenue by Application (2023-2028) & (USD Million)
Table 57. North America Vasomotor Symptoms of Menopause Treatment Revenue by Country (2017-2022) & (USD Million)
Table 58. North America Vasomotor Symptoms of Menopause Treatment Revenue by Country (2023-2028) & (USD Million)
Table 59. Europe Vasomotor Symptoms of Menopause Treatment Revenue by Type (2017-2022) & (USD Million)
Table 60. Europe Vasomotor Symptoms of Menopause Treatment Revenue by Type (2023-2028) & (USD Million)
Table 61. Europe Vasomotor Symptoms of Menopause Treatment Revenue by Application (2017-2022) & (USD Million)
Table 62. Europe Vasomotor Symptoms of Menopause Treatment Revenue by Application (2023-2028) & (USD Million)
Table 63. Europe Vasomotor Symptoms of Menopause Treatment Revenue by Country (2017-2022) & (USD Million)
Table 64. Europe Vasomotor Symptoms of Menopause Treatment Revenue by Country (2023-2028) & (USD Million)
Table 65. Asia-Pacific Vasomotor Symptoms of Menopause Treatment Revenue by Type (2017-2022) & (USD Million)
Table 66. Asia-Pacific Vasomotor Symptoms of Menopause Treatment Revenue by Type (2023-2028) & (USD Million)
Table 67. Asia-Pacific Vasomotor Symptoms of Menopause Treatment Revenue by Application (2017-2022) & (USD Million)
Table 68. Asia-Pacific Vasomotor Symptoms of Menopause Treatment Revenue by Application (2023-2028) & (USD Million)
Table 69. Asia-Pacific Vasomotor Symptoms of Menopause Treatment Revenue by Region (2017-2022) & (USD Million)
Table 70. Asia-Pacific Vasomotor Symptoms of Menopause Treatment Revenue by Region (2023-2028) & (USD Million)
Table 71. South America Vasomotor Symptoms of Menopause Treatment Revenue by Type (2017-2022) & (USD Million)
Table 72. South America Vasomotor Symptoms of Menopause Treatment Revenue by Type (2023-2028) & (USD Million)
Table 73. South America Vasomotor Symptoms of Menopause Treatment Revenue by Application (2017-2022) & (USD Million)
Table 74. South America Vasomotor Symptoms of Menopause Treatment Revenue by Application (2023-2028) & (USD Million)
Table 75. South America Vasomotor Symptoms of Menopause Treatment Revenue by Country (2017-2022) & (USD Million)
Table 76. South America Vasomotor Symptoms of Menopause Treatment Revenue by Country (2023-2028) & (USD Million)
Table 77. Middle East & Africa Vasomotor Symptoms of Menopause Treatment Revenue by Type (2017-2022) & (USD Million)
Table 78. Middle East & Africa Vasomotor Symptoms of Menopause Treatment Revenue by Type (2023-2028) & (USD Million)
Table 79. Middle East & Africa Vasomotor Symptoms of Menopause Treatment Revenue by Application (2017-2022) & (USD Million)
Table 80. Middle East & Africa Vasomotor Symptoms of Menopause Treatment Revenue by Application (2023-2028) & (USD Million)
Table 81. Middle East & Africa Vasomotor Symptoms of Menopause Treatment Revenue by Country (2017-2022) & (USD Million)
Table 82. Middle East & Africa Vasomotor Symptoms of Menopause Treatment Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Vasomotor Symptoms of Menopause Treatment Picture
Figure 2. Global Vasomotor Symptoms of Menopause Treatment Revenue Market Share by Type in 2021
Figure 3. Estetrol
Figure 4. Fezolinetant
Figure 5. FP-101
Figure 6. HBN-2
Figure 7. Others
Figure 8. Vasomotor Symptoms of Menopause Treatment Revenue Market Share by Application in 2021
Figure 9. Hospital Picture
Figure 10. Homecare Picture
Figure 11. Clinic Picture
Figure 12. Global Vasomotor Symptoms of Menopause Treatment Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 13. Global Vasomotor Symptoms of Menopause Treatment Revenue and Forecast (2017-2028) & (USD Million)
Figure 14. Global Vasomotor Symptoms of Menopause Treatment Revenue Market Share by Region (2017-2028)
Figure 15. Global Vasomotor Symptoms of Menopause Treatment Revenue Market Share by Region in 2021
Figure 16. North America Vasomotor Symptoms of Menopause Treatment Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Europe Vasomotor Symptoms of Menopause Treatment Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. Asia-Pacific Vasomotor Symptoms of Menopause Treatment Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. South America Vasomotor Symptoms of Menopause Treatment Revenue (USD Million) and Growth Rate (2017-2028)
Figure 20. Middle East and Africa Vasomotor Symptoms of Menopause Treatment Revenue (USD Million) and Growth Rate (2017-2028)
Figure 21. Vasomotor Symptoms of Menopause Treatment Market Drivers
Figure 22. Vasomotor Symptoms of Menopause Treatment Market Restraints
Figure 23. Vasomotor Symptoms of Menopause Treatment Market Trends
Figure 24. Amgen Inc. Recent Developments and Future Plans
Figure 25. EndoCeutics, Inc. Recent Developments and Future Plans
Figure 26. Euroscreen S.A. Recent Developments and Future Plans
Figure 27. MenoGeniX, Inc. Recent Developments and Future Plans
Figure 28. Mithra Pharmaceuticals S.A. Recent Developments and Future Plans
Figure 29. Pherin Pharmaceuticals, Inc. Recent Developments and Future Plans
Figure 30. Pivot Pharmaceuticals Inc Recent Developments and Future Plans
Figure 31. Radius Health, Inc. Recent Developments and Future Plans
Figure 32. TherapeuticsMD, Inc. Recent Developments and Future Plans
Figure 33. Global Vasomotor Symptoms of Menopause Treatment Revenue Share by Players in 2021
Figure 34. Vasomotor Symptoms of Menopause Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 35. Global Top 3 Players Vasomotor Symptoms of Menopause Treatment Revenue Market Share in 2021
Figure 36. Global Top 10 Players Vasomotor Symptoms of Menopause Treatment Revenue Market Share in 2021
Figure 37. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 38. Global Vasomotor Symptoms of Menopause Treatment Revenue Share by Type in 2021
Figure 39. Global Vasomotor Symptoms of Menopause Treatment Market Share Forecast by Type (2023-2028)
Figure 40. Global Vasomotor Symptoms of Menopause Treatment Revenue Share by Application in 2021
Figure 41. Global Vasomotor Symptoms of Menopause Treatment Market Share Forecast by Application (2023-2028)
Figure 42. North America Vasomotor Symptoms of Menopause Treatment Sales Market Share by Type (2017-2028)
Figure 43. North America Vasomotor Symptoms of Menopause Treatment Sales Market Share by Application (2017-2028)
Figure 44. North America Vasomotor Symptoms of Menopause Treatment Revenue Market Share by Country (2017-2028)
Figure 45. United States Vasomotor Symptoms of Menopause Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Canada Vasomotor Symptoms of Menopause Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. Mexico Vasomotor Symptoms of Menopause Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. Europe Vasomotor Symptoms of Menopause Treatment Sales Market Share by Type (2017-2028)
Figure 49. Europe Vasomotor Symptoms of Menopause Treatment Sales Market Share by Application (2017-2028)
Figure 50. Europe Vasomotor Symptoms of Menopause Treatment Revenue Market Share by Country (2017-2028)
Figure 51. Germany Vasomotor Symptoms of Menopause Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. France Vasomotor Symptoms of Menopause Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. United Kingdom Vasomotor Symptoms of Menopause Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Russia Vasomotor Symptoms of Menopause Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Italy Vasomotor Symptoms of Menopause Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Asia-Pacific Vasomotor Symptoms of Menopause Treatment Sales Market Share by Type (2017-2028)
Figure 57. Asia-Pacific Vasomotor Symptoms of Menopause Treatment Sales Market Share by Application (2017-2028)
Figure 58. Asia-Pacific Vasomotor Symptoms of Menopause Treatment Revenue Market Share by Region (2017-2028)
Figure 59. China Vasomotor Symptoms of Menopause Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Japan Vasomotor Symptoms of Menopause Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. South Korea Vasomotor Symptoms of Menopause Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. India Vasomotor Symptoms of Menopause Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Southeast Asia Vasomotor Symptoms of Menopause Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Australia Vasomotor Symptoms of Menopause Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. South America Vasomotor Symptoms of Menopause Treatment Sales Market Share by Type (2017-2028)
Figure 66. South America Vasomotor Symptoms of Menopause Treatment Sales Market Share by Application (2017-2028)
Figure 67. South America Vasomotor Symptoms of Menopause Treatment Revenue Market Share by Country (2017-2028)
Figure 68. Brazil Vasomotor Symptoms of Menopause Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Argentina Vasomotor Symptoms of Menopause Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Middle East and Africa Vasomotor Symptoms of Menopause Treatment Sales Market Share by Type (2017-2028)
Figure 71. Middle East and Africa Vasomotor Symptoms of Menopause Treatment Sales Market Share by Application (2017-2028)
Figure 72. Middle East and Africa Vasomotor Symptoms of Menopause Treatment Revenue Market Share by Country (2017-2028)
Figure 73. Turkey Vasomotor Symptoms of Menopause Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Saudi Arabia Vasomotor Symptoms of Menopause Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. UAE Vasomotor Symptoms of Menopause Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Methodology
Figure 77. Research Process and Data Source

Table of Contents

Related reports :

(Sep 22)

This report studies the global Elderly Wheelchair production, demand, key manufacturers, and key regions. This report is a detailed a...

(Sep 22)

According to our (Global Info Research) latest study, the global Elderly Wheelchair market size was valued at USD million in 2021 and is for...

(Sep 22)

Suture anchors are broadly used for attaching soft tissue (e.g., tendons, ligaments, and meniscus) to the bone and have become essential dev...

(Sep 22)

Suture anchors are broadly used for attaching soft tissue (e.g., tendons, ligaments, and meniscus) to the bone and have become essential dev...

(Sep 22)

Barbed sutures are primarily used in cosmetic surgery. In recent years there has been an increasing uptake in the use of barbed sutures, par...

(Sep 22)

Barbed sutures are primarily used in cosmetic surgery. In recent years there has been an increasing uptake in the use of barbed sutures, par...

Global Info Research

GLOBAL VASOMOTOR SYMPTOMS OF MENOPAUSE TREATMENT MARKET 2022 BY COMPANY, REGIONS, TYPE AND APPLICATION, FORECAST TO 2028

Share this report on:

Subscription Option


Using our subscription option, you get access to Market Research Reports and industry data of Medical Devices market as per your needs. Get the best of Medical Devices research reports by utilizing your research budgets in an optimum way. Contact for details

Contact for reports

*

We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy